Beyond Meat (BYND, $150.68) gets rating downgrade from JP Morgan, on lofty valuation concerns
Beyond Meat, maker of plant-based meat substitute, got a rating downgrade from analysts at JPMorgan, as the latter expressed concerns that the fundamentals are not supporting the stock’s rally.
JPMorgan analysts Ken Goldman lowered his rating on the Beyond Meat shares to 'underweight' from 'neutral', with a price target of $122 per share.
Over the past six months, Beyond Meat shares have rallied by more than +190% - something that Goldman feels was "above and beyond” what they consider rational “even for a good company like Beyond Meat". According to the analyst, fundamentals are "sluggish” for the food group. He also cited strong competition from rivals such as Impossible Foods, and the apprehension among some restaurants to add its products to menus amid the coronavirus pandemic.
Tickeron's analysis shows:
BYND is in upward trend: price rose above 50-day moving average on September 08, 2020
BYND moved above its 50-day Moving Average on September 08, 2020 date and that indicates a change from a downward trend to an upward trend. In 3 of 3 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
Current price $150.68 crossed the resistance line at $151.94 and is trading between $151.94 resistance and $143.00 resistance lines. Throughout the month of 08/17/20 - 09/17/20, the price experienced a +25% Uptrend. During the week of 09/10/20 - 09/17/20, the stock enjoyed a +10% Uptrend growth.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 08, 2020. You may want to consider a long position or call options on BYND as a result. In 15 of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for BYND just turned positive on August 20, 2020. Looking at past instances where BYND's MACD turned positive, the stock continued to rise in 4 of 7 cases over the following month. The odds of a continued upward trend are 57%.
The 10-day Moving Average for BYND crossed bullishly above the 50-day moving average on September 09, 2020. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +7.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where BYND advanced for three days, in 67 of 84 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
BYND broke above its upper Bollinger Band on September 16, 2020. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BYND entered a downward trend on September 09, 2020. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
Tickeron has a positive outlook on this ticker and predicts a further increase by more than 4.00% within the next month with a likelihood of 78%. During the last month, the daily ratio of advancing to declining volumes was 3.93 to 1.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. BYND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BYND's P/B Ratio (25.17) is very high in comparison to the industry average of (4.14). BYND has a moderately low P/E Ratio (0.00) as compared to the industry average of (27.10). BYND's Projected Growth (PEG Ratio) (0.00) is slightly lower than the industry average of (0.94). Dividend Yield (0.00) settles around the average of (2.24) among similar stocks. BYND's P/S Ratio (21.95) is very high in comparison to the industry average of (2.92).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BYND's RSI Oscillator peaks and leaves overbought zone
The 10-day RSI Indicator for BYND moved out of overbought territory on August 14, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 instances where the indicator moved out of the overbought zone. In 19 of the 19 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BYND as a result. In 88 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BYND turned negative on August 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 38 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
BYND moved below its 50-day moving average on August 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BYND crossed bearishly below the 50-day moving average on August 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BYND entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where BYND advanced for three days, in 186 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.123) is normal, around the industry mean (5.800). P/E Ratio (0.000) is within average values for comparable stocks, (35.515). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.868). BYND has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.059). P/S Ratio (0.506) is also within normal values, averaging (4.432).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. BYND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company, which offers plant-based meat products
Industry FoodMajorDiversified
Advertisement